Coagulation laboratory tests

PT - Prothrombin time

Last author update: 1 November 2012
Last staff update: 15 October 2021 (update in progress)

Copyright: 2002-2023,, Inc.

PubMed Search: Prothrombin time [title]

Jeremy C. Parsons, M.D.
Page views in 2022: 283
Page views in 2023 to date: 233
Cite this page: Parsons JC. PT - Prothrombin time. website. Accessed November 29th, 2023.
Definition / general
  • Most commonly performed laboratory coagulation test
  • Measures clotting time from factor VII activation through fibrin formation (i.e. extrinsic and common pathway)
  • Used as screening test and to monitor warfarin anticoagulation; can only detect single factor deficiencies if level is 15 - 45% of normal
  • Anticoagulant is usually 3.2% sodium citrate (recommended by Clinical and Laboratory Standards Institute; 3.8% sodium citrate causes prolonged PT if samples are < 80% filed compared to 100% filled; no difference in result with 3.2% citrate between filled volumes of 70% and 100% (Arch Pathol Lab Med 1997;121:956)
  • Test should use a thromboplastin that is insensitive to heparin in therapeutic range
  • PT is more sensitive to deficiencies in common pathway than aPTT
  • Warfarin monitoring
    • Warfarin is monitored using INR (international normalized ratio), which standardizes PT results for patients on oral anticoagulants
    • Goal is INR of 2 - 3
    • Calculated as INR = (patient PT / mean normal PT)ISI, where ISI is the International Sensitivity Index which is used to calibrate a particular batch of thromboplastin reagent to a universal standard (seebelow)
    • PT / INR should be checked daily at onset of warfarin use until dose and INR are stable (usually at least a week since half life of factors II and X are long), then need to check decreases gradually to every 4 weeks
    • May be improved by instrument-specific International Sensitivity Index (ISI) values, in-house calibrators or calibration curves (Arch Pathol Lab Med 2004;128:308); ISI measures sensitivity of PT reagent to factor deficiencies (1.0 is sensitive, 3.0 is insensitive, value determined by manufacturer)

  • Algorithm for working up a prolonged PT
    • (1) add heparinase; if PT corrects to normal, prolongation is due to presence of heparin
    • (2) mixing study (determine if etiology if factor deficiency or factor inhibitor); mix patient plasma with equal amount of normal plasma and determine the PT of the mixture after incubation for 2 hours
    • (a) if PT of mixture is normal, prolonged PT is due to factor deficiency; do assays for factors I, II, V, VII, X
    • (b) if PT of mixture is still prolonged, suggests presence of inhibitor (rare)
    • (c) if PTT of mixture is initially normal but becomes prolonged after incubation for 1 - 2 hours, may be due to factor V inhibitor (rare)
  • Reference interval should be established using at least 120 subjects for each reference population or subclass, and verified using at least 20 subjects
  • Usual reference range is 10 - 14 seconds, up to 16 seconds at birth and decreasing to adult values at age 6 months

  • Limitations: lupus anticoagulants, use of hirudin or argatroban - must use alternative assays, such as chromogenic factor X assays

  • Prolonged PT: usually due to deficiencies of factors I (fibrinogen), II, V, VII, X, less commonly due to an inhibitor or anticoagulant (heparin, hirudin, argatroban) and rarely lupus anticoagulant or specific factor inhibitor

  • Prolonged PT with normal PTT: warfarin or vitamin K deficiency (decreases function of factors II, VII, IX, X, protein C, protein S), liver dysfunction (decreases hepatic synthesis of all coagulation factors except factor VIII) and DIC

  • Markedly prolonged values may be due to long acting warfarin-like rodenticide toxicity (Arch Pathol Lab Med 2004;128:e181)
Back to top
Image 01 Image 02